Acobiom seeks 2M€ funds for Oncosnipe program
Biotech Finances Article – 03/27/2017
Acobiom, company that identifies RNA biomarkers for the development of diagnostics in personalized medicine, seeks 2M€ funds by the end of 2017. This raising funds occurs in part of its involvement in Oncosnipe, a R&D collaborative program leaded by Oncodesign to develop diagnostic tools in personalized medicine, in breast, lung and pancreatic cancers.
More information (in French): biotech-finances-762_p6